Jennifer La PhD
Adjunct Instructor, Hematology & Medical Oncology
72 E. Concord Street | (617) 638-7012jla2689@bu.edu
Sections
Hematology & Medical Oncology
Education
PhD, University of Chicago
MS, University of Chicago
Pharmacology, BS, Stony Brook University
Publications
Anand ST, Vo AD, La J, Do NV, Fillmore NR, Brophy M, Branch-Elliman W, Monach PA. Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration. JAMA Netw Open. 2024 Feb 05; 7(2):e240288. PMID: 38393725.
Published on 1/25/2024Monach PA, Anand ST, Fillmore NR, La J, Branch-Elliman W. Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022. MMWR Morb Mortal Wkly Rep. 2024 Jan 25; 73(3):57-61. PMID: 38271286.
Published on 1/25/2024Elbers DC, Fillmore NR, La J, Tosi HM, Ajjarapu S, Dhond R, Murray K, Valley D, Shannon C, Brophy MT, Do NV. Building Research Infrastructure to Develop Greater Learning Efficiencies (BRIDGE). Stud Health Technol Inform. 2024 Jan 25; 310:1131-1135. PMID: 38269991.
Published on 1/25/2024Do NV, Elbers DC, Fillmore NR, Ajjarapu S, Bergstrom SJ, Bihn J, Corrigan JK, Dhond R, Dipietro S, Dolgin A, Feldman TC, Goryachev SD, Huhmann LB, La J, Marcantonio PA, McGrath KM, Miller SJ, Nguyen VQ, Schneeloch GR, Sung FC, Swinnerton KN, Tarren AH, Tosi HM, Valley D, Vo AD, Yildirim C, Zheng C, Zwolinski R, Sarosy GA, Loose D, Shannon C, Brophy MT. Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial Workflow. Stud Health Technol Inform. 2024 Jan 25; 310:1086-1090. PMID: 38269982.
Published on 1/10/2024Hernandez KM, Venkat A, Elbers DC, Bihn JR, Brophy MT, Do NV, La J, Liu Q, Prokhorenkov A, Metoki-Shlubsky N, Sung FC, Paller CJ, Fillmore NR, Grossman RL. Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons. Cold Spring Harb Mol Case Stud. 2023 Dec; 9(4). PMID: 38050021.
Published on 11/15/2023Anand ST, Vo AD, La J, Brophy M, Do NV, Fillmore NR, Branch-Elliman W, Monach PA. Risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune-suppressive drugs: A nationwide cohort study of US Veterans. Transpl Infect Dis. 2024 Feb; 26(1):e14168. PMID: 37966134.
Published on 11/14/2023Trottier CA, La J, Li L, Fillmore NR, Monach PA, Doron S, Branch-Elliman W. Longitudinal trends in 30-day mortality attributable to SARS-CoV-2 among vaccinated and unvaccinated US veteran patients. Infect Control Hosp Epidemiol. 2024 Mar; 45(3):393-395. PMID: 37960943.
Published on 11/14/2023Fillmore NR, La J, Wu JT, Corrigan JK, Branch-Elliman W, Monach P, Brophy MT, Do NV, Munshi NC. Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders. Blood Adv. 2023 Nov 14; 7(21):6767-6770. PMID: 37647600.
Published on 11/11/2023Trottier C, La J, Li LL, Alsoubani M, Vo AD, Fillmore NR, Branch-Elliman W, Doron S, Monach PA. Maintaining the Utility of Coronavirus Disease 2019 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool. Clin Infect Dis. 2023 Nov 11; 77(9):1247-1256. PMID: 37348870.
Published on 10/24/2023DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, Hassan H, Yellapragada S, Abel GA, Gaziano JM, Do NV, Brophy M, Kim DH, Munshi NC, Fillmore NR, Driver JA. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023 Oct 24; 7(20):6275-6284. PMID: 37582048.